11/17/2014
OCT angiography offers high-resolution imaging of the deep retinal vasculature
11/14/2014 | Roisin McGuigan
Abbott and Zeiss join forces, Valeant and Allergan continue to battle
11/14/2014 | Jesper Hjortdal
More than three years of experience with this new kid on the refractive surgery block makes me think... this could be the future
11/14/2014 | Mark Hillen
Raised risk of central serous chorioretinopathy associated with Androgel or Testopill treatment
Are a significant number of users risking retinal damage?
What does analysis of the last five years of literature on branch retinal vein occlusion tell us about the priorities of the field and the major contributors to it?
Regeneron released preliminary data of the DRCR.net Protocol T trial. The DRCR.net hasn‘t, and won’t for a while.
11/13/2014 | Mark Hillen
Sitting Down With… John Kanellopoulos Clinical Professor of Ophthalmology, New York University Medical School, Partner at OMMA Eye Institute, and Founder and Scientific Manager of Laservision.gr Institute, Athens, Greece
10/16/2014 | Mark Hillen
What does analysis of the last five years of the literature on vitreomacular traction/ adhesion tell us about the priorities of the field and the major contributors to it?
10/15/2014
Sitting Down With… Charles McGhee, Director of the New Zealand National Eye Centre, University of Auckland, New Zealand.
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Redressing Representation
Living with TED: My Race from Patient to Advocate
How Dry Eye Disease Impacts Younger Patients
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: